Concourse Financial Group Securities, Inc. Evotec Se Transaction History

Concourse Financial Group Securities, Inc.

$1.52 Billion
Q1 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$6.89 - $11.4 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$8.33 - $11.89 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$9.63 - $13.36 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$9.63 - $13.36 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$8.95 - $12.48 $0 - $0	0 New	0 $0

Q1 2023 May 15, 2023	BUY	$8.11 - $10.53 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$7.8 - $9.85 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$8.4 - $28.4 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$10.78 - $15.5 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$12.93 - $23.46 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$22.0 - $25.77 $0 - $0	0 New	0 $0

Others Institutions Holding EVO

# of Institutions

Shares Held

347K

Call Options Held

Put Options Held

View Full List

About Evotec SE

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.7B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

More about EVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account